Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,072 | 1,100 | 707 | 309 | 156 |
| Income taxes - deferred | 5,848 | N/A | N/A | N/A | N/A |
| Accounts receivable | 7,042 | 4,591 | -14,231 | 240 | -2,560 |
| Accounts payable and accrued liabilities | -6,210 | -3,444 | 31,757 | 6,865 | N/A |
| Other Working Capital | 3,652 | 1,423 | 21,266 | 7,221 | -1,414 |
| Other Operating Activity | -172,533 | -157,742 | -136,629 | -42,624 | -41,839 |
| Operating Cash Flow | $-161,129 | $-154,072 | $-97,130 | $-27,989 | $-45,657 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -142 | -640 | -265 | -30 | -1,330 |
| Purchase Of Investment | N/A | N/A | -9,351 | -470 | -126 |
| Sale Of Investment | N/A | N/A | 741 | N/A | N/A |
| Purchase Sale Intangibles | 0 | -3 | 0 | -13 | N/A |
| Other Investing Activity | -8,051 | 16,405 | 780 | 0 | 0 |
| Investing Cash Flow | $-8,193 | $15,762 | $-8,095 | $-513 | $-1,456 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 47,944 | 55,841 | 14,950 | 25,000 |
| Debt Repayment | -59,533 | -10,458 | -40,602 | -3,597 | -11,954 |
| Common Stock Issued | 648,124 | 434 | 353,387 | 28,592 | 65,466 |
| Other Financing Activity | -41,284 | -9,713 | -33,336 | 8,088 | 0 |
| Financing Cash Flow | $547,307 | $28,207 | $335,290 | $48,033 | $78,512 |
| Exchange Rate Effect | -10,251 | 2,382 | -5,072 | N/A | N/A |
| Beginning Cash Position | 144,221 | 251,942 | 26,950 | 9,771 | 29,302 |
| End Cash Position | 516,685 | 144,221 | 251,942 | 29,302 | 60,701 |
| Net Cash Flow | $382,715 | $-110,103 | $230,064 | $19,531 | $31,399 |
| Free Cash Flow | |||||
| Operating Cash Flow | -161,129 | -154,072 | -97,130 | -27,989 | -45,657 |
| Capital Expenditure | -142 | -643 | -265 | -43 | -1,642 |
| Free Cash Flow | -161,271 | -154,715 | -97,395 | -28,032 | -47,299 |